137 related articles for article (PubMed ID: 31296901)
1. XPNPEP2 is associated with lymph node metastasis in prostate cancer patients.
Li F; Dai Y; Xu H; Huang K; Zhou Y; Luo D; Ma D; Xi L; Lv M; Ma X
Sci Rep; 2019 Jul; 9(1):10078. PubMed ID: 31296901
[TBL] [Abstract][Full Text] [Related]
2. D-PCa-2: a novel transcript highly overexpressed in human prostate and prostate cancer.
Weigle B; Kiessling A; Ebner R; Fuessel S; Temme A; Meye A; Schmitz M; Rieger MA; Ockert D; Wirth MP; Rieber EP
Int J Cancer; 2004 May; 109(6):882-92. PubMed ID: 15027122
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of Vitronectin Expression in Prostate Cancer and the Clinical Significance of the Association of Vitronectin Expression with Prostate Specific Antigen in Detecting Prostate Cancer.
Niu Y; Zhang L; Bi X; Yuan S; Chen P
Urol J; 2016 Mar; 13(1):2527-32. PubMed ID: 26945657
[TBL] [Abstract][Full Text] [Related]
5. Urinary microRNA-based signature improves accuracy of detection of clinically relevant prostate cancer within the prostate-specific antigen grey zone.
Salido-Guadarrama AI; Morales-Montor JG; Rangel-Escareño C; Langley E; Peralta-Zaragoza O; Cruz Colin JL; Rodriguez-Dorantes M
Mol Med Rep; 2016 Jun; 13(6):4549-60. PubMed ID: 27081843
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of Talin-1 expression associates with advanced pathological features and predicts lymph node metastases and biochemical recurrence of prostate cancer.
Xu N; Chen HJ; Chen SH; Xue XY; Chen H; Zheng QS; Wei Y; Li XD; Huang JB; Cai H; Sun XL
Medicine (Baltimore); 2016 Jul; 95(29):e4326. PubMed ID: 27442684
[TBL] [Abstract][Full Text] [Related]
7. XPNPEP2 is overexpressed in cervical cancer and promotes cervical cancer metastasis.
Cheng T; Wei R; Jiang G; Zhou Y; Lv M; Dai Y; Yuan Y; Luo D; Ma D; Li F; Xi L
Tumour Biol; 2017 Jul; 39(7):1010428317717122. PubMed ID: 28670957
[TBL] [Abstract][Full Text] [Related]
8. SPINK1 expression in relation to PTEN and ERG in matched primary and lymph node metastatic prostate cancer: Implications for biomarker development.
Huang KC; Bégin LR; Palanisamy N; Donnelly B; Bismar TA
Urol Oncol; 2016 May; 34(5):235.e1-10. PubMed ID: 26725250
[TBL] [Abstract][Full Text] [Related]
9. Semen miRNAs Contained in Exosomes as Non-Invasive Biomarkers for Prostate Cancer Diagnosis.
Barceló M; Castells M; Bassas L; Vigués F; Larriba S
Sci Rep; 2019 Sep; 9(1):13772. PubMed ID: 31551516
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
11. PCA3 and PSA gene activity correlates with the true tumor cell burden in prostate cancer lymph node metastases.
Tsaur I; Hennenlotter J; Oppermann E; Munz M; Kuehs U; Stenzl A; Schilling D
Cancer Biomark; 2015; 15(3):311-6. PubMed ID: 25769446
[TBL] [Abstract][Full Text] [Related]
12. Clinical Evaluation of FOXO1 as a Tumor Suppressor in Prostate Cancer.
Yang N; Wu J; Zhang T; Yang F; Shao J; He C; Qin L
Comput Math Methods Med; 2021; 2021():8773423. PubMed ID: 34552661
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic and prognostic value of serum miR-15a and miR-16-1 expression among egyptian patients with prostate cancer.
Zidan HE; Abdul-Maksoud RS; Elsayed WSH; Desoky EAM
IUBMB Life; 2018 May; 70(5):437-444. PubMed ID: 29522280
[TBL] [Abstract][Full Text] [Related]
14. Development of 3D Lymph Node Mimetic for Studying Prostate Cancer Metastasis.
Hakamivala A; Huang Y; Chang YF; Pan Z; Nair A; Hsieh JT; Tang L
Adv Biosyst; 2019 Sep; 3(9):e1900019. PubMed ID: 32648652
[TBL] [Abstract][Full Text] [Related]
15. Spread of prostate carcinoma to the perirectal lymph node basin: analysis of 112 rectal resections over a 10-year span for primary rectal adenocarcinoma.
Murray SK; Breau RH; Guha AK; Gupta R
Am J Surg Pathol; 2004 Sep; 28(9):1154-62. PubMed ID: 15316314
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of peroxiredoxins in prostate cancer: consistent upregulation of PRDX3 and PRDX4.
Basu A; Banerjee H; Rojas H; Martinez SR; Roy S; Jia Z; Lilly MB; De León M; Casiano CA
Prostate; 2011 May; 71(7):755-65. PubMed ID: 21031435
[TBL] [Abstract][Full Text] [Related]
17. HOXB13 protein expression in metastatic lesions is a promising marker for prostate origin.
Varinot J; Furudoï A; Drouin S; Phe V; Penna RR; Roupret M; Bitker MO; Cussenot O; Compérat E
Virchows Arch; 2016 May; 468(5):619-22. PubMed ID: 26931741
[TBL] [Abstract][Full Text] [Related]
18. [Early diagnosis of prostate cancer by combined use of Trp-p8 expression and PSA density of the transition zone].
Zhang XS; Zhang Y; Wu PX; Liu SJ; Zhou JY; Liu SX
Zhonghua Nan Ke Xue; 2015 Aug; 21(8):724-8. PubMed ID: 26442301
[TBL] [Abstract][Full Text] [Related]
19. DNA ploidy, serum prostate specific antigen, histological grade and immunohistochemistry as predictive parameters of lymph node metastases in T1-T3/M0 prostatic adenocarcinoma.
Berner A; Waere H; Nesland JM; Paus E; Danielsen HE; Fosså SD
Br J Urol; 1995 Jan; 75(1):26-32. PubMed ID: 7531589
[TBL] [Abstract][Full Text] [Related]
20. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
